Chinese Vathin Medical Completes Hundreds of Millions of Yuan Series Pre-B Financing

Hunan Vathin Medical Equipment Co., Ltd. (湖南省华芯医疗器械有限公司) completed a series Pre-B financing of hundreds of millions of yuan led by IDG Capital, followed by Founder Securities Investment (方正证券投资) and Xiangtan Caixin Chanxing Equity Investment (湘潭财信产兴).

This fund will be used to further expand product pipelines, increase investment in clinical trials, expand automated production lines, and strengthen international sales and marketing, to enhance its competitiveness in the field of single-use bronchoscopes.

In September 2021, Vathin Medical completed a series A financing of hundreds of millions of yuan led by River-Head Capital (阳光融汇资本) and followed by Lotus-Lake Capital (荷塘创投) and ZhongtouTonghe Investment (中投同和).

Founded in 2018, Vathin Medical focuses on a new generation of single-use bronchoscopes, medical robots, and automated precision diagnosis and treatment systems. Its endoscopes and consumables are widely applied in clinical departments such as respiratory, urology, gastroenterology, anorectal, ENT, gynecology, and orthopedics.

Headquartered in Xiangtan City, Hunan Province, Vathin Medical has subsidiaries in Germany, Shanghai, Beijing, Wuhan, Changsha, and Shenzhen. Olympus is the general agent of Vathin Medical in the United States. Vathin Medical’s innovative products have been exported to many developed countries including the United States, Germany, Japan, France, the United Kingdom, and Australia.